We are happy to annonce that VASCERN eHealth services project proposal was selected for the Connecting Europe Facility (CEF) EU co-funding, following the call for proposals (2018 CEF Telecom Call – eHealth (CEF-TC-2018-4)) in 2018. That will allow us to receive a maximum EU contribution of 210 000€ (a co-funding…
VASCERN Spotlights: Caroline van den Bosch In this month’s VASCERN Spotlights we meet Caroline van den Bosch from the Netherlands. Caroline is the European Patient Advocacy Group (ePAG) Co-Chair for the Vascular Anomalies Working Group (VASCA WG) and shares with us how she became involved in VASCERN, the history behind…
This month the Heritable Thoracic Aortic Diseases Working Group (HTAD WG) held a videoconference meeting using the Clinical Patient Management System (CPMS) in order to discuss a complex patient case. Eight Healthcare Professional (HCP) Representatives from 7 European countries (Belgium, France, Germany, Hungary, The Netherlands, Sweden and the United Kingdom)…
The GeneReviews, article on Lymphedema-Distichiasis syndrome (LDS), a disease covered by the Pediatric and Primary Lymphedema Working Group (PPL WG), has just been updated. It is co-authored by Prof Sahar Mansour (Co-Chair of the VASCERN PPL WG) and Dr. Peter Mortimer (PPL-WG member). Lymphedema-distichiasis syndrome is a syndromic lymphedema disorder…
A new rare disease project, called Share4Rare, has just been launched! This project, funded by a Horizon2020 grant from the European Commission, is a digital platform that aims build a virtual community that allows rare disease patients, carers, clinicians and researchers to join forces. Their goal: ” Create the largest…
The document outlining the Third Programme for the Unionʼs action in the field of health (Work Programme for 2019) is now available to view here Many actions concern specifically the European Reference Networks: Rare disease registries for the European Reference Networks (2.1, pages 8-9, announcing a future call for proposals…
In order to support the European Commission’s actions and to improve the management of rare diseases, Eurordis has launched the #Pledge4RD campaign to challenge Members of the European Parliament (MEP) to pledge their support for rare diseases before the upcoming European elections (May 23-36, 2019). Their idea is simple: contact…
With the 15 deliverables of our second year of VASCERN activities submitted to the European Commission on February 28th, 2019, VASCERN is now looking towards the future! Under the 5 year Framework Partnership Agreement (FPA) with the European Commission, VASCERN has signed the new Specific Grant Agreement (SGA) for Years…
